Evidence map›Paper›PMID 37814228›Full record

Trial reportBMC cancer2023

Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma.

Yankun Gao, Xia Wang, Xiaoying Zhao, Chao Zhu, Cuiping Li, Jianying Li, Xingwang Wu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yankun GaoDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
Xia WangDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
Xiaoying ZhaoDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
Chao ZhuDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
Cuiping LiDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
Jianying LiCT Research Center, GE Healthcare China, Shanghai, 210000, China.
Xingwang WuDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. duobi2004@126.com.

Funding

2021 Medical Empowerment-Pilot Elite Research Project Special Fund NO.XM_HR_YXFN_2021_05_19
6 · The paper itself

Abstract

backgroundSmall (< 4 cm) clear cell renal cell carcinoma (ccRCC) is the most common type of small renal cancer and its prognosis is poor. However, conventional radiological characteristics obtained by computed tomography (CT) are not sufficient to predict the nuclear grade of small ccRCC before surgery.

methodsA total of 113 patients with histologically confirmed ccRCC were randomly assigned to the training set (n = 67) and the testing set (n = 46). The baseline and CT imaging data of the patients were evaluated statistically to develop a clinical model. A radiomics model was created, and the radiomics score (Rad-score) was calculated by extracting radiomics features from the CT images. Then, a clinical radiomics nomogram was developed using multivariate logistic regression analysis by combining the Rad-score and critical clinical characteristics. The receiver operating characteristic (ROC) curve was used to evaluate the discrimination of small ccRCC in both the training and testing sets.

resultsThe radiomics model was constructed using six features obtained from the CT images. The shape and relative enhancement value of the nephrographic phase (REV of the NP) were found to be independent risk factors in the clinical model. The area under the curve (AUC) values for the training and testing sets for the clinical radiomics nomogram were 0.940 and 0.902, respectively. Decision curve analysis (DCA) revealed that the radiomics nomogram model was a better predictor, with the highest degree of coincidence.

conclusionThe CT-based radiomics nomogram has the potential to be a noninvasive and preoperative method for predicting the WHO/ISUP grade of small ccRCC.

Indexed as

Carcinoma, Renal CellCarcinoma, Small CellKidney NeoplasmsLung NeoplasmsSmall Cell Lung CarcinomaHumansNomogramsRetrospective StudiesTomography, X-Ray ComputedWorld Health OrganizationClear cell renal cell carcinomaComputed tomographyRadiomics nomogramSmall renal massWHO/ISUP grade

Identifiers

PMID37814228
PMCPMC10561466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.